Pricing for the new Alzheimer's drug Leqembi at $26,500 a year is a fraud on America.
The new Alzheimer's drug Leqembi may give those taking it about six months to a year more mobility. For that, the company wants you to pay $26,500. The drug had its genesis at a university.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.